Understanding the Role of CT in Infectious Disease Management

Computed Tomography (CT) has evolved from a specialized imaging tool into a cornerstone of infectious disease diagnostics. While the COVID-19 pandemic thrust chest CT into the spotlight—demonstrating its ability to rapidly identify ground‑glass opacities and organizing pneumonia—its utility extends across a broad spectrum of bacterial, viral, fungal, and parasitic infections. CT provides cross‑sectional images with superior soft‑tissue contrast, enabling clinicians to detect infections earlier, define their extent more precisely, and guide interventions such as biopsy or drainage. This article examines how CT is used to detect, characterize, and monitor infectious diseases beyond the pandemic, highlighting specific applications, limitations, and emerging innovations.

How CT Scans Support Infectious Disease Detection

CT imaging works by combining multiple X‑ray projections to generate detailed axial slices of the body. Intravenous contrast further enhances visualization of inflammatory changes, abscesses, and vascular involvement. In infectious disease, the key advantages of CT over plain radiography include the ability to detect small lesions, evaluate complex anatomic regions (such as the mediastinum or retroperitoneum), and differentiate between infectious and non‑infectious processes. For example, CT can distinguish a lung abscess from an empyema, or an intra‑abdominal collection from a simple fluid accumulation.

The following sections illustrate how CT is applied to specific infectious disease scenarios beyond COVID‑19, drawing on evidence and guidelines from radiology and infectious disease societies.

Respiratory Infections Beyond COVID‑19

Community‑acquired pneumonia (CAP) remains a leading cause of hospitalization worldwide. CT is not indicated for all cases of CAP, but it is invaluable when the diagnosis is uncertain, when complications are suspected (e.g., parapneumonic effusion, lung abscess, necrotizing pneumonia), or when the patient is immunocompromised. In immunocompromised hosts, CT frequently reveals patterns that suggest specific pathogens: for instance, invasive aspergillosis often presents with a halo sign (ground‑glass opacity surrounding a nodule), while Pneumocystis jirovecii pneumonia shows bilateral ground‑glass opacities. CT also helps differentiate viral pneumonias (such as influenza or respiratory syncytial virus) from bacterial pneumonia by identifying diffuse ground‑glass vs. lobar consolidation [1].

Fungal infections of the lung, particularly in patients with hematologic malignancies or transplant recipients, are another domain where CT excels. The Fungal Infection Diagnosis and Management guidelines emphasize that CT findings such as macronodules, halo signs, and reverse halo signs are highly suggestive of invasive mold infections, often prompting earlier antifungal therapy.

Tuberculosis: CT for Detection and Activity Assessment

Pulmonary tuberculosis (TB) remains a global health challenge, and CT improves diagnostic accuracy compared with chest radiography. CT can detect subtle centrilobular nodules (tree‑in‑bud pattern), cavitations, and lymphadenopathy that may be missed on plain films. In cases of smear‑negative or extrapulmonary TB, CT of the chest, spine, or abdomen can reveal characteristic features such as vertebral body destruction with paravertebral abscess (Pott disease) or mesenteric lymphadenopathy with central necrosis. The World Health Organization’s TB diagnostic guidelines now include CT as a recommended tool when additional certainty is needed, particularly for drug‑resistant TB monitoring.

CT is also used to assess disease activity by evaluating the evolution of lesions over time. Persistent cavitation, enlarging nodules, or new infiltrates on serial scans suggest active infection, whereas stable or shrinking lesions indicate response to therapy. This ability to track lesion morphology is crucial for managing multidrug‑resistant TB, where treatment duration is long and relapses are common.

Abdominal and Pelvic Infections

Intra‑abdominal infections—such as diverticulitis, appendicitis, and pyogenic liver abscesses—are frequently evaluated with CT because of its high sensitivity for identifying extraluminal air, fluid collections, and organ‑specific inflammation. In patients with pancreatitis, CT helps diagnose infected necrosis by detecting gas bubbles within necrotic tissue. For renal infections, CT can differentiate between acute pyelonephritis (wedge‑shaped hypoenhancing areas) and a renal abscess (rim‑enhancing fluid collection), guiding the need for percutaneous drainage.

In pelvic inflammatory disease (PID), CT may show tubo‑ovarian abscesses, thickened fallopian tubes, and inflammatory changes in the pelvic fat. Although ultrasound remains the first‑line imaging modality for gynecologic infections, CT is valuable when the diagnosis is unclear or when complications (such as abscess rupture) are suspected.

Neurological Infections

CT of the brain is often the initial imaging study for suspected meningitis or encephalitis, especially in emergency settings. While MRI is more sensitive for parenchymal involvement and meningeal enhancement, CT can detect complications such as hydrocephalus, cerebral edema, and abscess formation. In patients with bacterial meningitis, contrast‑enhanced CT may show leptomeningeal enhancement and help identify underlying sinusitis or mastoiditis as the source.

For cerebral abscesses, CT demonstrates a characteristic ring‑enhancing lesion with surrounding edema, and follow‑up scans monitor the response to antibiotic therapy or surgical drainage. In immunocompromised patients, CT can reveal toxoplasmosis (multiple ring‑enhancing lesions) or progressive multifocal leukoencephalopathy (hypodense white‑matter lesions without mass effect).

Musculoskeletal Infections

CT is less commonly used for soft‑tissue infections than MRI, but it remains excellent for evaluating osteomyelitis, particularly in the axial skeleton and in patients with contraindications to MRI (e.g., pacemakers). CT can demonstrate cortical destruction, periosteal reaction, and sequestrum formation in chronic osteomyelitis. In diabetic foot infections, CT helps assess the extent of bone involvement and guides amputation planning. For septic arthritis, CT may show joint effusion, erosions, and gas within the joint, though ultrasound and MRI are often preferred for early diagnosis.

Tracking Disease Progression and Treatment Response

Beyond initial detection, CT plays a critical role in longitudinal monitoring. Serial imaging allows clinicians to objectively measure changes in lesion size, density, and number, providing surrogate endpoints for treatment efficacy.

Chronic and Recurrent Infections

In chronic pulmonary aspergillosis, CT is the imaging gold standard for monitoring progression. The presence of an intracavitary fungus ball, expanding cavities, or pleural thickening indicates worsening disease, while resolution of these features suggests successful antifungal therapy. Similarly, in patients with bronchiectasis and recurrent infections, CT can track the extent of airway damage and identify new areas of consolidation that may require additional treatment.

For recurrent abscesses (e.g., pyogenic liver abscesses in patients with biliary disease), CT helps determine whether a collection has resolved completely after drainage or whether new loculated fluid requires re‑intervention. By providing a roadmap for interventional procedures, CT reduces the need for exploratory surgery.

Monitoring Antifungal and Antibiotic Therapy

Clinical trials increasingly use CT‑based measures such as “total lesion volume” or “number of nodules” as endpoints for antifungal efficacy. For example, in invasive candidiasis, CT can show the evolution of hepatosplenic lesions (target‑like microabscesses) during therapy. In bacterial pneumonia, early CT response (reduction in consolidation size) correlates with clinical improvement and can identify non‑responders who may need a change in antibiotic regimen. The Infectious Diseases Society of America guidelines for pneumonia recommend CT when the clinical response is suboptimal, as it can reveal empyema or lung abscess that was not apparent on chest X‑ray.

Assessing Treatment Complications

CT also detects complications of infectious disease therapy. For instance, prolonged use of antifungal agents such as voriconazole can cause periostitis, which may be identified on CT as periosteal new bone formation. Similarly, the immune reconstitution inflammatory syndrome (IRIS) in HIV‑positive patients treated for TB can be indistinguishable from worsening TB on imaging; CT findings such as new lymphadenopathy with central necrosis or worsening pulmonary infiltrates require careful correlation with clinical and laboratory data.

Limitations and Ongoing Challenges

Despite its strengths, CT has important limitations. Ionizing radiation exposure is a concern, particularly for patients who require repeated scans. Although low‑dose protocols reduce radiation by 50–80%, they may compromise image quality for subtle findings. Alternative modalities—such as ultrasound (for superficial infections) and MRI (for neurological and musculoskeletal infections)—are preferred when radiation avoidance is paramount. Additionally, intravenous contrast carries a risk of allergic reactions and nephrotoxicity, limiting its use in patients with renal impairment.

Cost and accessibility also hinder widespread CT use in resource‑limited settings where infectious disease burden is highest. In many high‑prevalence regions for TB and HIV, CT scanners are scarce, and reliance on chest X‑ray or clinical algorithms remains standard.

Differentiating Infection from Malignancy or Inflammation

CT findings are often non‑specific. A lung nodule with a halo sign may be caused by aspergillosis, but also by hemorrhage, vasculitis, or metastatic disease. Similarly, ring‑enhancing brain lesions can represent abscess, toxoplasmosis, lymphoma, or primary brain tumor. Infectious disease specialists must integrate CT findings with microbiological, serological, and histopathological data to avoid misdiagnosis. Advanced techniques—such as dual‑energy CT (which provides material decomposition) and dual‑phase contrast enhancement—may improve specificity but are not yet routine.

Future Directions: AI, Dual‑Energy CT, and Low‑Dose Innovations

Technological advances are addressing many of CT’s current limitations. Artificial intelligence (AI) algorithms are being developed to automatically detect infectious foci, quantify disease burden (e.g., pneumonia severity scores), and predict treatment response from CT images. A study using deep learning on chest CT for TB detection achieved sensitivity comparable to expert radiologists [2]. Such tools could reduce interpretation time and assist radiologists in high‑volume settings.

Dual‑energy CT (DECT) allows characterization of tissues based on their atomic number, potentially distinguishing purulent from non‑purulent fluid collections without direct aspiration. DECT also enables virtual non‑contrast images, reducing the need for separate non‑contrast scans. Meanwhile, photon‑counting CT—a newer detector technology—offers higher spatial resolution and lower radiation doses, making it ideal for imaging small structures such as peripheral lung nodules or small abscesses.

Low‑dose CT protocols are already being refined for lung cancer screening, and their principles are being adapted for infectious disease surveillance. For example, very low‑dose chest CT (equivalent to 2–3 chest X‑rays) can screen for TB in high‑risk populations while keeping cumulative radiation within safe limits. Combined with AI‑assisted interpretation, these protocols have the potential to bring CT‑level diagnostic accuracy to resource‑constrained settings through portable scanners.

Conclusion: CT as a Versatile Tool in the Infectious Disease Arsenal

Computed Tomography has moved far beyond its initial role in oncology and trauma. In the post‑COVID era, its applications in infectious disease continue to expand—from diagnosing pneumonia in immunocompromised hosts to monitoring the response of drug‑resistant tuberculosis. While radiation exposure, cost, and specificity limitations remain, ongoing innovations in low‑dose imaging, dual‑energy techniques, and artificial intelligence promise to make CT even more valuable in the fight against infectious diseases. Clinicians who understand both the strengths and constraints of CT can use it to improve patient outcomes while minimizing unnecessary harms.